Short-term Outcomes of Iridoplasty for Persistent Angle Closure Despite Patent Iridotomies

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

January 31, 2013

Conditions
Angle Closure GlaucomaGlaucoma
Interventions
PROCEDURE

Argon Laser Peripheral Iridoplasty

ALPI was applied with a VISULAS diode laser of 532 nm (Carl Zeiss Meditec, Dublin, CA) by the same ophthalmologist (JML). Twenty to 40 spots of 400 mW power with 500 microns of size and duration of 500 ms were applied. Power was modified arbitrarily until an effective iris contraction was obtained. It was considered an effective contraction as that which causes a concentric movement around the laser spot, with minimal iris pigmentation and immediate angle opening observed through the lens mirrors using a Goldmann lens. Power was lowered if there was any bursting sound perceived, pigment dispersion, air bubbles or considerable pain.

Trial Locations (1)

06800

"Fundación Conde de Valenciana Ophthalmology Institute", Mexico City

All Listed Sponsors
lead

Instituto de Oftalmología Fundación Conde de Valenciana

OTHER

NCT02199158 - Short-term Outcomes of Iridoplasty for Persistent Angle Closure Despite Patent Iridotomies | Biotech Hunter | Biotech Hunter